News

July 20, 2016July 20, 2016

Psoriasis: Symptom Severity, Quality of Life Sometimes Go Hand in Hand

News

Psoriasis is a dermatological disease that deeply impacts patients, not only physically but also emotionally when it comes to body image, self-esteem and overall quality of life. Researchers at the Medical University ... Read more

July 19, 2016

Review of Mental Health Problems in Psoriasis Patients Emphasizes Inflammatory Mechanisms

News

Reviewing published studies of the connection between psoriasis and mental health conditions, researchers in Portugal noted that the link is likely maintained by cascades of inflammatory factors triggered by chronic ... Read more

July 18, 2016July 18, 2016

First Combination Foam Spray for Psoriasis, Enstilar, Now Available in UK

News

Adults with psoriasis who live in the United Kingdom will now have a new treatment option available to manage the disease. LEO Pharma’s Enstilar is the first plaque psoriasis treatment available ... Read more

July 18, 2016July 18, 2016

Pro-inflammatory Immune Cell Receptor May Be Key to Start of Psoriasis

News

Researchers in Spain recently identified a receptor of the immune system that appears to play a pivotal role in the development of psoriasis, highlighting a possible new therapeutic avenue for the disease. The study, “CD69 ... Read more

July 14, 2016

FDA Panel Recommends Amgen’s ABP 501 as Biosimilar to Humira

News

The Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) recommends licensing Amgen’s ABP 501 as a biosimilar product to AbbVie’s FDA-approved Humira (adalimumab) for the treatment of patients with ... Read more

July 13, 2016

August, Psoriasis Awareness Month, to Bring Weekly ‘Challenges’ and Health Tips

News

This August, Psoriasis Awareness Month, the National Psoriasis Foundation (NPF) will launch a campaign with the twin goals of helping psoriasis patients to take better care of their health and of raising awareness about the 7.5 million ... Read more

July 7, 2016July 7, 2016

TNF Inhibitors Seen to Lower Cardiovascular Disease Risk in Psoriasis Patients

News

TNF inhibitors are commonly used to treat psoriasis and psoriatic arthritis patients, who are also at high risk of cardiovascular disease. Researchers investigated whether these drugs play a role in elevating that ... Read more

July 1, 2016July 1, 2016

Psoriasis Patients at Risk of Metabolic Syndrome and Cardiovascular Changes, Study from India Finds

News

A recent study evaluated the prevalence of metabolic syndrome and subclinical atherosclerosis in an Indian population with chronic plaque psoriasis, and found a higher prevalence in psoriasis patients when compared to controls. ... Read more

June 30, 2016July 1, 2016

Global Psoriasis Survey Shows 85% of US Patients Faced Discrimination

News

Results from the largest global survey on moderate-to-severe psoriasis patients, called Clear About Psoriasis Survey, were released recently by Novartis Pharmacueticals. Comprising 25 groups worldwide, it was the largest collaboration led by ... Read more

June 28, 2016

Role of Interleukin-33 in Skin Psoriasis, Inflammatory Diseases Studied by Researchers

News

Researchers investigated the role of a molecule, interleukin (IL)-33, in a skin psoriasis mouse model to further understand the role of this cytokine in inflammatory diseases. The findings suggest the molecule ... Read more